@FierceMedDev: FDA warns of criminals hocking stolen Covidien stapler reloads. More | Follow @FierceMedDev
@MarkHFierce: Biotronik won FDA approval for ICD/CRT-D devices, keeping it in the global race to unveil new products in the space. Story | Follow @MarkHFierce
@DamianFierce: Stan Musial rises from the grave and takes a job at a specialty pharma outfit. Amazing, really. Release | Follow @DamianFierce
> Elixir Medical gained FDA approval to begin enrolling patients in EXCELLA III, a multisite U.S. trial to test the DESyne Nx Novolimus Eluting Coronary Stent System. The results will fuel a PMA application. Release
> The FDA has affixed its most-serious Class I tag to Maquet's March recall of SERVO-i Ventilator battery modules. More
> Medical device companies are increasingly responding to cost concerns expressed by insurers, with less of a focus on doctors and patients, a new report commissioned by MassMEDIC concludes. Story
> Navidea Biopharmaceuticals ($NAVB) took a $7 million loss last quarter as the company ramps up commercialization of its Lymphoseek diagnostic aid. Results
> Insulin pump maker Insulet ($PODD) enjoyed a 14% stock surge on Tuesday after reporting $57.4 million in revenue during the 2013 first quarter, a 20% spike that also comes with narrowed net losses. Story
> Cancer Genetics ($CGIX) has partnered with Nikon Instruments to distribute oncology-focused diagnostics technologies in Italy. Item
> A team of researchers from the University of Southern California and elsewhere are developing a microchip implant to help restore memories in patients with impaired brains, with human trials expected within two years. Story
Biotech News
@FierceBiotech: Nimbus Discovery announced agreement with Shire focused on small molecule treatments for rare genetic diseases. Release | Follow @FierceBiotech
@JohnCFierce: Painful to watch Vivus ($VVUS) scratching out sales for its weight drug. It's not built to market a drug like that. More | Follow @JohnCFierce
@RyanMFierce: Pfizer opts to keep running Accelrys software in its labs. Article | Follow @RyanMFierce
> Genomics, Biotechnology's Oldest Next Big Thing. Industry Voices
> Startup biotech charges into PhII with $23M bankroll for rare disease drugs. Article
> Takeda beefs up new vaccines arm with $250M bolt-on buyout of Inviragen. News
Pharma News
@FiercePharma: India's own drugmakers are turned off their home market by gov't policy. For them, it's price caps. More | Follow @FiercePharma
@EricPFierce: Rapidly growing Sagent takes control of FDA approved China plant that it is ready to produce products. Article | Follow @EricPFierce
> U.S. Judge lashes out at FDA over its Plan B maneuver. Story
> The pharma spin-offs have just begun, bankers figure. News
> GSK taps "independent" experts to control trial-data access. More
Drug Delivery News
@MichaelGFierce: Frederick National Lab leads nanotech boom with cancer drug delivery. Report | Follow @MichaelGFierce
> "Buckyball" capsule lets researchers steer drugs to target. Article
> Math model could choose most effective drug delivery nanoparticle. Story
> Langer's Kala touts positive results for topical wet AMD treatment. Report
> "Smart" insulin nanoparticle controls blood sugar levels for up to 10 days. More